239 related articles for article (PubMed ID: 3905335)
1. Current management of Hodgkin's disease.
Behrens BC; Young RC; DeVita VT
Drugs; 1985 Oct; 30(4):355-67. PubMed ID: 3905335
[TBL] [Abstract][Full Text] [Related]
2. The risk of acute leukemia in patients treated for Hodgkin's disease is significantly higher aft [see bined modality programs than after chemotherapy alone and is correlated with the extent of radiotherapy and type and duration of chemotherapy: a case-control study.
Brusamolino E; Anselmo AP; Klersy C; Santoro M; Orlandi E; Pagnucco G; Lunghi F; Maurizi-Enrici R; Baroni CD; Lazzarino M; Mandelli F; Bernasconi C
Haematologica; 1998 Sep; 83(9):812-23. PubMed ID: 9825578
[TBL] [Abstract][Full Text] [Related]
3. The role of MOPP chemotherapy in early stage Hodgkin's disease.
Mauch P; Hellman S
Hematol Oncol; 1984; 2(1):66-9. PubMed ID: 6376318
[No Abstract] [Full Text] [Related]
4. Immunoblastic lymphoma following therapy for Hodgkin's disease. A case report.
Casini M; Pianezze G; Fabris P; Cemin S; Coser P
Haematologica; 1986; 71(1):50-2. PubMed ID: 3084357
[No Abstract] [Full Text] [Related]
5. Low risk of secondary leukemias after chemotherapy without mechlorethamine in childhood Hodgkin's disease. German-Austrian Pediatric Hodgkin's Disease Group.
Schellong G; Riepenhausen M; Creutzig U; Ritter J; Harbott J; Mann G; Gadner H
J Clin Oncol; 1997 Jun; 15(6):2247-53. PubMed ID: 9196137
[TBL] [Abstract][Full Text] [Related]
6. Hodgkin's disease, splenectomy and secondary leukemia.
Centurioni R; Brianzoni F; Leoni P; Danieli G
Haematologica; 1993; 78(4):258-9. PubMed ID: 8294062
[No Abstract] [Full Text] [Related]
7. [Acute leukemia in patients treated for Hodgkin's disease].
Boccaccio P; Rosa F; Casciaro S; D'Elia P; Romagnoli M; Ghio R
Recenti Prog Med; 1988 Jan; 79(1):32-7. PubMed ID: 3375542
[No Abstract] [Full Text] [Related]
8. Two cycles of MOPP and definitive radiotherapy for stage IIIA and IIIB Hodgkin's disease.
Fuller LM; Hagemeister FB
Recent Results Cancer Res; 1989; 117():197-204. PubMed ID: 2602645
[No Abstract] [Full Text] [Related]
9. The intergroup Hodgkin's disease in children. A study of stages I and II.
Gehan EA; Sullivan MP; Fuller LM; Johnston J; Kennedy P; Fryer C; Gilchrist GS; Hays DM; Hanson W; Heller R
Cancer; 1990 Mar; 65(6):1429-37. PubMed ID: 2407336
[TBL] [Abstract][Full Text] [Related]
10. Hodgkin's disease and acute leukemia. Is it a true association?
Avilés A; Díaz-Maqueo JC; Ayala JR; Cortés HD; García EL
Arch Med Res; 1992; 23(1):65-8. PubMed ID: 1308794
[TBL] [Abstract][Full Text] [Related]
11. Mediastinal Hodgkin's disease. Significance of mediastinal involvement in early stage Hodgkin's disease.
Mauch P; Hellman S
Hematol Oncol; 1984; 2(1):69-72. PubMed ID: 6547403
[No Abstract] [Full Text] [Related]
12. Hodgkin's disease and the risk of acute leukemia in successfully treated patients.
Valagussa P; Bonadonna G
Haematologica; 1998 Sep; 83(9):769-70. PubMed ID: 9825571
[No Abstract] [Full Text] [Related]
13. Hodgkin's disease: controversies and challenges for the future.
Tura S; Canellos G; Goldstone A; Longo D; McMillan A; Urba W; Zinzani PL
Haematologica; 1991; 76(4):263-79. PubMed ID: 1724436
[No Abstract] [Full Text] [Related]
14. [Acute myeloid leukemia after treatment of Hodgkin's disease].
Carneiro PC; Pereira ED; Mitteldorf CS; Martinez GA; Beitler B; Pozzi DH
Rev Hosp Clin Fac Med Sao Paulo; 1989; 44(2):87-90. PubMed ID: 2616992
[TBL] [Abstract][Full Text] [Related]
15. Osteonecrosis of sternum and rib in a patient treated for Hodgkin's disease.
Blijham GH; Vermeulen A; Mendes de Leon DE
Cancer; 1985 Nov; 56(9):2292-4. PubMed ID: 3840407
[TBL] [Abstract][Full Text] [Related]
16. Bulky mediastinal Hodgkin's disease: results of a combined modality approach (ABVD/MOPP alternating chemotherapy plus radiation therapy).
De Lena M; Ditonno P; Lorusso V; Timurian A; Pellecchia A; Brandi M; Berardi F; Marzullo F
Haematologica; 1993; 78(4):230-5. PubMed ID: 7507457
[TBL] [Abstract][Full Text] [Related]
17. [Non-Hodgkin's lymphoma secondary to Hodgkin's disease treated with chemo- and radiotherapy. Report of a case].
Gamboa Domínguez A; Pita Ramírez L; Hurtado Monroy R; Angeles-Angeles A
Rev Invest Clin; 1992; 44(3):393-8. PubMed ID: 1283228
[TBL] [Abstract][Full Text] [Related]
18. CCNU, vinblastine, procarbazine and prednisone (CVPP) with extended-field radiotherapy in the treatment of early unfavorable Hodgkin's disease. A prospective study on behalf of the Gruppo Italiano per lo Studio dei Linfomi (GISL).
Gobbi PG; Pieresca C; Cavanna L; Corbella F; Vallisa D; Federico M; Formisano R; Carotenuto M; Merli F; Callea V; Angrilli F; Silingardi V
Haematologica; 1996; 81(6):503-12. PubMed ID: 9009437
[TBL] [Abstract][Full Text] [Related]
19. Early-stage Hodgkin's disease: current approaches to treatment.
Rusthoven JJ; MacKenzie R
Can Med Assoc J; 1985 Aug; 133(3):193-8. PubMed ID: 3893668
[TBL] [Abstract][Full Text] [Related]
20. High-dose BEAM chemotherapy with autologous haemopoietic stem cell transplantation for Hodgkin's disease is unlikely to be associated with a major increased risk of secondary MDS/AML.
Harrison CN; Gregory W; Hudson GV; Devereux S; Goldstone AH; Hancock B; Winfield D; MacMillan AK; Hoskin P; Newland AC; Milligan D; Linch DC
Br J Cancer; 1999 Oct; 81(3):476-83. PubMed ID: 10507773
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]